Back to top

Jarden Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

In a report released yesterday, Steven Wheen from Jarden maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$20.70. The comp...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: